InvestorsHub Logo

I ll be back

12/31/20 11:31 AM

#13959 RE: RCRanger03 #13956

Agree....in the land of OTC one could easily draw that conclusion.

I'd like to see that $400M project for 2022 be repeated by the new BIGT team. It just seems so outrageous...



I'm investing heavy based on two key facts here:

First:
We have a NAZ traded company (SRAX) who understands the importance of not OVER stating revenue models, since they don't live in the land of OTC. As we all know, SRAX is spinning off BigT into FPVD (shell) to move their plan forward.

Second:
BigT business model is tied too the world of a BIG (no pun intended) and upcoming problem for companies working in the internet has it's tied to data sharing.

Anyone who doesn't believe me should take a look at the California law and the new law working its why through Congress.

My money says, "if" the new team delivers on their new business plan, this stock will have a revenue that exceeds the $400m forecast.

The bigger question in my mind is not the revenue forecast, but how soon the company deals with the AS. However, with all the above, I'll gladly own the stock down here and load it up, until BigT shares "the rest of the story".